Bio-Techne
TECH
#1479
Rank
NZ$20.21 B
Marketcap
$127.20
Share price
-0.50%
Change (1 day)
32.25%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Earnings for Bio-Techne (TECH)

Earnings in 2024 (TTM): NZ$0.33 Billion

According to Bio-Techne's latest financial reports the company's current earnings are NZ$1.15 Billion. In 2023 the company made an earning of NZ$0.44 Billion a decrease over its 2022 earnings that were of NZ$0.55 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Bio-Techne from 1991 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) NZ$0.33 B-25.38%
2023 NZ$0.44 B-19.25%
2022 NZ$0.55 B50.77%
2021 NZ$0.36 B-1.3%
2020 NZ$0.37 B-15.46%
2019 NZ$0.43 B82.56%
2018 NZ$0.23 B11.13%
2017 NZ$0.21 B1.19%
2016 NZ$0.21 B-12.64%
2015 NZ$0.24 B-9.33%
2014 NZ$0.26 B2.19%
2013 NZ$0.26 B-1.7%
2012 NZ$0.26 B-3.5%
2011 NZ$0.27 B6.2%
2010 NZ$0.26 B-0.59%
2009 NZ$0.26 B2.78%
2008 NZ$0.25 B14.95%
2007 NZ$0.22 B15.14%
2006 NZ$0.19 B11.66%
2005 NZ$0.17 B17.05%
2004 NZ$0.14 B18.06%
2003 NZ$0.12 B26.06%
2002 NZ$99.49 M22.66%
2001 NZ$81.11 M9.92%
2000 NZ$73.79 M43.92%
1999 NZ$51.27 M31.99%
1998 NZ$38.84 M29.61%
1997 NZ$29.97 M31.62%
1996 NZ$22.77 M34.65%
1995 NZ$16.91 M16.09%
1994 NZ$14.56 M29.85%
1993 NZ$11.21 M6.35%
1992 NZ$10.54 M152%
1991 NZ$4.18 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$11.48 B 3,305.22%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$1.69 Billion-599.04%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.80 B 730.58%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$6.83 B 1,927.05%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.24 B-28.40%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
NZ$13.87 B 4,014.66%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$16.44 Million-104.87%๐Ÿ‡บ๐Ÿ‡ธ USA